The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from GlobeNewswire (a Nasdaq OMX company)

Merrimack Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

Thursday, May 10, 2012

Merrimack Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference15:06 EDT Thursday, May 10, 2012CAMBRIDGE, Mass., May 10, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President and Chief Executive Officer, is scheduled to present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16, 2012 at 8:00 a.m. (PDT) at the Encore at the Wynn Hotel in Las Vegas, Nevada. A live webcast of Merrimack's presentation can be accessed by visiting the investor relations section of the company's website at investors.merrimackpharma.com. A replay of the webcast will be archived on Merrimack's website for two weeks following the presentation.About Merrimack Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has five targeted therapeutic oncology candidates in clinical development.CONTACT: Investor & Media Contact: Kathleen Petrozzelli Gallagher Corporate Communications, Merrimack 617-441-1043 kgallagher@merrimackpharma.com Media Contact: Betsy Stevenson RaymondStevenson Healthcare Communications 860-984-1424 betsy@raymondstevenson.com